Sage's postpartum depression drug is approved. Now comes the hard part

The Food and Drug Administration on Tuesday issued its first-ever approval of a postpartum depression therapy, offering a new treatment option for the roughly one in nine women who experience this kind of disorder. The question remains, however, of how accessible that option will end up being for patients. Branded as Zulresso, the therapy supplies… Read More »

Is Medical Pot a Blessing for Seniors?

WEDNESDAY, March 20, 2019 (HealthDay News) — Legalized medical pot may be a boon to older Americans, boosting their health and ability to work, a new study finds. “Research [on medical marijuana] has largely ignored older adults even though they experience the highest rates of medical issues that could be treated with medical marijuana,” said… Read More »

Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges

Sage Therapeutics has the first-ever approval for a prescription drug for postpartum depression, thanks to the FDA’s Tuesday nod for Zulresso. But it also has a number of big challenges ahead. Regulators greenlighted the product—a one-time injection—after a three-month delay, which they took to give themselves some extra time to work on a risk evaluation… Read More »